This is the classic website, which will be retired eventually. Please visit the modernized instead.
Working… Menu

Efficacy and Safety of Losmapimod in Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD) (FSHD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04003974
Recruitment Status : Completed
First Posted : July 1, 2019
Last Update Posted : February 10, 2022
Information provided by (Responsible Party):
Fulcrum Therapeutics

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : January 28, 2021
Actual Study Completion Date : January 28, 2021
Certification/Extension First Submitted : January 27, 2022

Publications automatically indexed to this study by Identifier (NCT Number):